Integrins in angiogenesis and lymphangiogenesis

Blood vessels promote tumour growth, and both blood and lymphatic vessels facilitate tumour metastasis by serving as conduits for the transport of tumour cells to new sites. Angiogenesis and lymphangiogenesis are regulated by integrins, which are members of a family of cell surface receptors whose ligands are extracellular matrix proteins and immunoglobulin superfamily molecules. Select integrins promote endothelial cell migration and survival during angiogenesis and lymphangiogenesis, whereas other integrins promote pro-angiogenic macrophage trafficking to tumours. Several integrin-targeted therapeutic agents are currently in clinical trials for cancer therapy. Here, we review the evidence implicating integrins as a family of fundamental regulators of angiogenesis and lymphangiogenesis.

[1]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[2]  Masahiro Inoue,et al.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.

[3]  D. Davidson,et al.  Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[4]  S. Mousa,et al.  Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. , 2000, The American journal of pathology.

[5]  Erik Sahai,et al.  Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.

[6]  David A. Cheresh,et al.  Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.

[7]  M. Detmar,et al.  Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Cheresh,et al.  An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. , 1995, Journal of cell science.

[9]  N. Boudreau,et al.  The Homeobox Transcription Factor Hox D3 Promotes Integrin α5β1 Expression and Function during Angiogenesis* , 2004, Journal of Biological Chemistry.

[10]  David A. Cheresh,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2007, Nature.

[11]  S. Kim,et al.  Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. , 2000, The Journal of biological chemistry.

[12]  Y. Ozaki,et al.  Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  F. Kruse,et al.  Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. , 2007, The American journal of pathology.

[14]  K. Alitalo,et al.  Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.

[15]  D. Davidson,et al.  Central Roles of &agr;5&bgr;1 Integrin and Fibronectin in Vascular Development in Mouse Embryos and Embryoid Bodies , 2002 .

[16]  B. Garmy-Susini,et al.  Integrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors , 2006 .

[17]  D. Stupack.  Integrins as a distinct subtype of dependence receptors , 2005, Cell Death and Differentiation.

[18]  H. Friess,et al.  A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer , 2006, BMC Cancer.

[19]  A. Harris,et al.  Tumor-Associated Macrophages in Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.

[20]  P. Campochiaro,et al.  Suppression and Regression of Choroidal Neovascularization by Systemic Administration of an α5β1 Integrin Antagonist , 2006, Molecular Pharmacology.

[21]  西江 昭弘.  Macrophage Infiltration and Heme Oxygenase-1 Expression Correlate with Angiogenesis in Human Gliomas , 2001 .

[22]  Semi Kim,et al.  Regulation of Angiogenesis in Vivo by Ligation of Integrin α5β1 with the Central Cell-Binding Domain of Fibronectin , 2000 .

[23]  David C. Smith,et al.  Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design. , 2006, Clinical genitourinary cancer.

[24]  A. Beaudet,et al.  LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. , 1997, The Journal of clinical investigation.

[25]  D. Schlaepfer,et al.  Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.

[26]  F. Giancotti,et al.  Integrin β4 signaling promotes tumor angiogenesis , 2004 .

[27]  E. Plow,et al.  Integrin-ligand interactions: a year in review. , 1994, Current opinion in cell biology.

[28]  Dahua Zhang,et al.  Effects of a monoclonal anti-αvβ3 integrin antibody on blood vessels—A pharmacodynamic study , 2006, Investigational New Drugs.

[29]  Jonathan R. Lindner,et al.  Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to &agr;v-Integrins , 2003, Circulation.

[30]  M. Günel,et al.  Expression of Integrins in Cerebral Arteriovenous and Cavernous Malformations , 2006, Neurosurgery.

[31]  R. Figlin,et al.  Phase II study of volociximab (M200), an α5β1 anti-integrin antibody in refractory metastatic clear cell renal cell cancer (RCC). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  C. Magi-Galluzzi,et al.  Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma , 2006, Modern Pathology.

[33]  E. Chavakis,et al.  Role of (cid:1) 2-integrins for homing and neovascularization capacity of endothelial progenitor cells , 2004 .

[34]  L. Lau,et al.  Identification of a Novel Integrin α6β1 Binding Site in the Angiogenic Inducer CCN1 (CYR61)* , 2003, Journal of Biological Chemistry.

[35]  R. Hynes,et al.  Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. , 2007, Developmental biology.

[36]  L. Reichardt,et al.  beta8 integrins are required for vascular morphogenesis in mouse embryos. , 2002, Development.

[37]  Michael C. Schmid,et al.  Myeloid cell trafficking and tumor angiogenesis. , 2007, Cancer letters.

[38]  D. Sheppard,et al.  Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. , 2007, The Journal of biological chemistry.

[39]  H. Ueda,et al.  Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. , 2004, Cardiovascular research.

[40]  J. Qin,et al.  A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. , 2002, Cell.

[41]  R. Klemke,et al.  Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. , 1997, The Journal of clinical investigation.

[42]  M. Trikha,et al.  CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivo , 2004, International journal of cancer.

[43]  C. Lewis,et al.  Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. , 2004, Blood.

[44]  R. Hwang,et al.  Integrin α4β1–VCAM-1–mediated adhesion between endothelial and mural cells is required for blood vessel maturation , 2005 .

[45]  David C. Smith,et al.  EMD121974 (NSC 707544, cilengitide) in asymptomatic metastatic androgen independent prostate cancer (AIPCa) patients (pts): A randomized trial by the Prostate Cancer Clinical Trials Consortium (NCI 6372) , 2007 .

[46]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[47]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[48]  D. Housman,et al.  Selective ablation of αv integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death , 2004, Development.

[49]  R. Hynes,et al.  Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. , 1995, Development.

[50]  G. Yehia,et al.  Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. , 1996, Nature genetics.

[51]  A. Sonnenberg,et al.  Epithelial detachment due to absence of hemidesmosomes in integrin β4 null mice , 1996, Nature Genetics.

[52]  M. Arnaout,et al.  Integrin structure, allostery, and bidirectional signaling. , 2005, Annual review of cell and developmental biology.

[53]  N. Funel,et al.  Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma , 2004, Journal of Clinical Pathology.

[54]  N. Wang,et al.  Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761. , 2007, Investigative ophthalmology & visual science.

[55]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[56]  D. Stupack,et al.  A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. , 2006, The Journal of clinical investigation.

[57]  D. Cheresh,et al.  An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization , 1995 .

[58]  S. Croul,et al.  Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis. , 2007, Circulation research.

[59]  A. Joussen,et al.  The role of integrin alpha5beta1 in the regulation of corneal neovascularization. , 2007, Experimental eye research.

[60]  Amnon Peled,et al.  Subsecond Induction of α4 Integrin Clustering by Immobilized Chemokines Stimulates Leukocyte Tethering and Rolling on Endothelial Vascular Cell Adhesion Molecule 1 under Flow Conditions , 2000, The Journal of experimental medicine.

[61]  R. Hynes,et al.  Defective Associations between Blood Vessels and Brain Parenchyma Lead to Cerebral Hemorrhage in Mice Lacking αv Integrins , 2002, Molecular and Cellular Biology.

[62]  D. Taverna,et al.  Reduced blood vessel formation and tumor growth in alpha5-integrin-negative teratocarcinomas and embryoid bodies. , 2001, Cancer research.

[63]  D. Shaw,et al.  Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours , 2006, British Journal of Cancer.

[64]  R. Hynes,et al.  Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins , 1998, Cell.

[65]  H. Jin,et al.  Integrins: roles in cancer development and as treatment targets , 2004, British Journal of Cancer.

[66]  W. Gerald,et al.  Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. , 2007, The Journal of clinical investigation.

[67]  C. Pritchard,et al.  MEK kinase activity is not necessary for Raf‐1 function , 2001, The EMBO journal.

[68]  R. Kalluri,et al.  β1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[69]  N. Jonjić,et al.  Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma , 2002, Virchows Archiv.

[70]  R. Klemke,et al.  Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis , 1998, The Journal of cell biology.

[71]  A. Sica,et al.  Altered macrophage differentiation and immune dysfunction in tumor development. , 2007, The Journal of clinical investigation.

[72]  J. Pollard,et al.  Tumor-associated macrophages press the angiogenic switch in breast cancer. , 2007, Cancer research.

[73]  D. Sheppard,et al.  The EIIIA Segment of Fibronectin Is a Ligand for Integrins α9β1 and α4β1Providing a Novel Mechanism for Regulating Cell Adhesion by Alternative Splicing* , 2002, The Journal of Biological Chemistry.

[74]  M. Bednarski,et al.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.

[75]  Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis , 1998 .

[76]  D. Hallahan,et al.  Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. , 2006, International journal of radiation oncology, biology, physics.

[77]  D. Santini,et al.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.

[78]  F. Giancotti,et al.  Integrin beta4 signaling promotes tumor angiogenesis. , 2004, Cancer cell.

[79]  A. Hauschild,et al.  Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes , 2005, Modern Pathology.

[80]  A. Joussen,et al.  The role of integrin α5β1 in the regulation of corneal neovascularization , 2007 .

[81]  M. Nguyen,et al.  Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. , 2005, Blood.

[82]  J. Varner.  The sticky truth about angiogenesis and thrombospondins. , 2006, The Journal of clinical investigation.

[83]  D. Sheppard,et al.  The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. , 2005, The Journal of biological chemistry.

[84]  E. Tschachler,et al.  Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. , 1999, The American journal of pathology.

[85]  A. Harris,et al.  Expression of vascular endothelial growth factor by macrophages is up‐regulated in poorly vascularized areas of breast carcinomas , 2000, The Journal of pathology.

[86]  R. Clark,et al.  Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. , 1982, The Journal of investigative dermatology.

[87]  L. Ellis,et al.  Inhibition of integrin α5β1 function with a small peptide (ATN‐161) plus continuous 5‐FU infusion reduces colorectal liver metastases and improves survival in mice , 2003, International journal of cancer.

[88]  D. Boturyn,et al.  Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers. , 2007, Anti-cancer agents in medicinal chemistry.

[89]  T. Mikkelsen,et al.  Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  M. Humphries,et al.  The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. , 1991, The Journal of biological chemistry.

[91]  Semi Kim,et al.  Inhibition of endothelial cell survival and angiogenesis by protein kinase A. , 2002, The Journal of clinical investigation.

[92]  D. Cheresh,et al.  Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.

[93]  R. Hynes,et al.  Embryonic mesodermal defects in alpha 5 integrin-deficient mice. , 1993, Development.

[94]  J. Lindquist,et al.  Cooperation between VEGF and beta3 integrin during cardiac vascular development. , 2007, Blood.

[95]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[96]  J. Sosman,et al.  A phase II, randomized, open-label study evaluating the antitumor activity of MEDI-522, a humanized monoclonal antibody directed against the human alpha v beta 3 (avb3) integrin, {+/-} dacarbazine (DTIC) in patients with metastatic melanoma (MM) , 2005 .

[97]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[98]  R. Flavell,et al.  Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis , 2005, The Journal of cell biology.

[99]  山城 重雄.  Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors , 1995 .

[100]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[101]  J. Calvete,et al.  Inhibitory Effects of MLDG-containing Heterodimeric Disintegrins Reveal Distinct Structural Requirements for Interaction of the Integrin α9β1 with VCAM-1, Tenascin-C, and Osteopontin* , 2000, The Journal of Biological Chemistry.

[102]  S. Kuwada.  Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. , 2007, Current opinion in molecular therapeutics.

[103]  F. Kayaselçuk,et al.  Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. , 2006, Journal of experimental & clinical cancer research : CR.

[104]  D. Sheppard,et al.  The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. , 2002, The Journal of biological chemistry.

[105]  J. Brugge,et al.  IL-6 involvement in epithelial cancers. , 2007, The Journal of clinical investigation.

[106]  D. Hicklin,et al.  Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in β3-Integrin–Deficient Mice , 2004, Cancer Research.

[107]  Stephen C. Blacklow,et al.  Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation , 2002, Nature Structural Biology.

[108]  D. Cheresh,et al.  Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[109]  D. A. Hanson,et al.  Focal adhesion kinase: in command and control of cell motility , 2005, Nature Reviews Molecular Cell Biology.

[110]  V. Dzau,et al.  Essential Role of ICAM-1/CD18 in Mediating EPC Recruitment, Angiogenesis, and Repair to the Infarcted Myocardium , 2006, Circulation research.

[111]  Jens Eickhoff,et al.  Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion , 2005, Clinical Cancer Research.

[112]  Jun Qin,et al.  A Structural Mechanism of Integrin αIIbβ3 “Inside-Out” Activation as Regulated by Its Cytoplasmic Face , 2002, Cell.

[113]  King C.P. Li,et al.  A review: Integrin αvβ3-targeted molecular imaging and therapy in angiogenesis , 2005 .

[114]  A. Sonnenberg,et al.  Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice. , 1996, Nature genetics.

[115]  T. Byzova,et al.  Integrin signaling is critical for pathological angiogenesis , 2006, The Journal of experimental medicine.

[116]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[117]  V. Quaranta,et al.  Integrin cytoplasmic domains mediate inside-out signal transduction , 1994, The Journal of cell biology.

[118]  M. Makale,et al.  Methods to study lymphatic vessel integrins. , 2007, Methods in enzymology.

[119]  T Pawson,et al.  The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. , 2000, Genes & development.

[120]  F. Kruse,et al.  Inhibition of Inflammatory Lymphangiogenesis by Integrin α5 Blockade , 2007 .

[121]  D. Hallahan,et al.  Integrin αvβ3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non–small-cell lung cancer models , 2006 .

[122]  T. N. Campbell,et al.  Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[123]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[124]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[125]  Dahua Zhang,et al.  Effects of a monoclonal anti-alphavbeta3 integrin antibody on blood vessels - a pharmacodynamic study. , 2007, Investigational new drugs.

[126]  N. Boudreau,et al.  The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. , 2004, The Journal of biological chemistry.

[127]  L. Coussens,et al.  The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. , 2005, Cancer research.

[128]  R. Hynes,et al.  Embryonic mesodermal defects in 5 integrin-deficient mice , 1996 .

[129]  Timothy A. Springer,et al.  Association of the Membrane Proximal Regions of the α and β Subunit Cytoplasmic Domains Constrains an Integrin in the Inactive State* , 2001, The Journal of Biological Chemistry.

[130]  S. Croul,et al.  Interaction of &agr;9&bgr;1 Integrin With Thrombospondin-1 Promotes Angiogenesis , 2007 .

[131]  H. Krell,et al.  β1 Integrin Is Essential for Teratoma Growth and Angiogenesis , 1997, The Journal of cell biology.

[132]  Robert V Farese,et al.  Fatal Bilateral Chylothorax in Mice Lacking the Integrin α9β1 , 2000, Molecular and Cellular Biology.

[133]  D. Sheppard,et al.  Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling , 2002, The Journal of cell biology.

[134]  D. Taverna,et al.  Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. , 2002, Nature medicine.

[135]  A. Pozzi,et al.  Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[136]  D. Cheresh,et al.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis , 2004, The Journal of cell biology.

[137]  Satoshi Hirakawa,et al.  VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis , 2005, The Journal of experimental medicine.

[138]  T. Yankeelov,et al.  (cid:1) 2 (cid:2) 1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell–specific manner , 2022 .

[139]  Y. Liu,et al.  Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61). , 2003, The Journal of biological chemistry.

[140]  D. Cheresh.  Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[141]  G. Oliver,et al.  Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.

[142]  F. Giancotti,et al.  Tyrosine Phosphorylation of the β4 Integrin Cytoplasmic Domain Mediates Shc Signaling to Extracellular Signal-regulated Kinase and Antagonizes Formation of Hemidesmosomes* , 2001, The Journal of Biological Chemistry.

[143]  M. Karin,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2009, Nature.

[144]  R. Hynes,et al.  Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. , 1997, Blood.

[145]  P. Campochiaro,et al.  Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist. , 2006, Molecular pharmacology.

[146]  R. Fässler,et al.  Consequences of lack of beta 1 integrin gene expression in mice. , 1995, Genes & development.

[147]  S. Rafii,et al.  Thrombopoietic Cells and the Bone Marrow Vascular Niche , 2007, Annals of the New York Academy of Sciences.

[148]  P. Bohlen,et al.  VEGF‐A promotes tissue repair‐associated lymphatic vessel formation via VEGFR‐2 and the α1β1 and α2β1 integrins , 2004 .

[149]  Chandra L. Theesfeld,et al.  Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[150]  D. Sheppard,et al.  The Lymphangiogenic Vascular Endothelial Growth Factors VEGF-C and -D Are Ligands for the Integrin α9β1* , 2005, Journal of Biological Chemistry.

[151]  Semi Kim,et al.  Regulation of Integrin αvβ3-mediated Endothelial Cell Migration and Angiogenesis by Integrin α5β1 and Protein Kinase A* , 2000, The Journal of Biological Chemistry.

[152]  J. Becker,et al.  Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. , 1996, The Journal of clinical investigation.

[153]  D. Taverna,et al.  Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins , 2002, Nature Medicine.

[154]  D. Sheppard,et al.  Integrin α9β1 Directly Binds to Vascular Endothelial Growth Factor (VEGF)-A and Contributes to VEGF-A-induced Angiogenesis* , 2007, Journal of Biological Chemistry.

[155]  G. Yehia,et al.  Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice , 1996, Nature Genetics.

[156]  Robert A. Beckman,et al.  Phase I Evaluation of a Fully Human Anti–αv Integrin Monoclonal Antibody (CNTO 95) in Patients with Advanced Solid Tumors , 2007, Clinical Cancer Research.

[157]  R. Hwang,et al.  Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. , 2005, The Journal of clinical investigation.

[158]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[159]  P. Bohlen,et al.  VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[160]  M. Bednarski,et al.  A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[161]  S. Tsutsui,et al.  Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. , 2005, Oncology reports.

[162]  K. Miyazono,et al.  Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. , 2007, Molecular biology of the cell.

[163]  D. Cheresh,et al.  Definition of two angiogenic pathways by distinct alpha v integrins. , 1995, Science.

[164]  Robert V Farese,et al.  Normal Development, Wound Healing, and Adenovirus Susceptibility in β5-Deficient Mice , 2000, Molecular and Cellular Biology.

[165]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[166]  M. Bednarski,et al.  Tumor Regression by Targeted Gene Delivery to the Neovasculature , 2002, Science.

[167]  E. Fuchs,et al.  Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival , 1996, The Journal of cell biology.

[168]  J. Pollard,et al.  Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.

[169]  R. Hynes,et al.  Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. , 1999, The Journal of clinical investigation.

[170]  R. Pedersen,et al.  Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. , 1995, Genes & development.

[171]  B. Saville,et al.  Absence of Adverse Effects in Cynomolgus Macaques Treated with CNTO 95, a Fully Human Anti-αv Integrin Monoclonal Antibody, Despite Widespread Tissue Binding , 2005, Clinical Cancer Research.

[172]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[173]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[174]  S. Kennel,et al.  Integrin Regulation by Vascular Endothelial Growth Factor in Human Brain Microvascular Endothelial Cells , 2006, Journal of Biological Chemistry.

[175]  Li Zhang,et al.  Ligand Binding to Integrins* , 2000, The Journal of Biological Chemistry.

[176]  David A. Cheresh,et al.  Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins , 2001, The Journal of cell biology.